Charles M Baum - Net Worth and Insider Trading
Charles M Baum Net Worth
The estimated net worth of Charles M Baum is at least $10 Million dollars as of 2024-05-02. Charles M Baum is the President,Founder,Head of R&D of Mirati Therapeutics Inc and owns about 168,777 shares of Mirati Therapeutics Inc (MRTX) stock worth over $10 Million. Charles M Baum is also the Director of Array BioPharma Inc and owns about 10,000 shares of Array BioPharma Inc (ARRY) stock worth over $389,500. Details can be seen in Charles M Baum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charles M Baum has not made any transactions after 2023-01-04 and currently still holds the listed stock(s).
Transaction Summary of Charles M Baum
Charles M Baum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles M Baum owns 7 companies in total, including BCTG Acquisition Corp (BCTG) , Mirati Therapeutics Inc (MRTX) , and Immunomedics Inc (IMMU) among others .
Click here to see the complete history of Charles M Baum’s form 4 insider trades.
Insider Ownership Summary of Charles M Baum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCTG | BCTG Acquisition Corp | 2020-09-02 | director |
| MRTX | Mirati Therapeutics Inc | 2023-01-04 | director & President & CEO |
| IMMU | Immunomedics Inc | 2020-10-23 | director |
 | | 2021-04-01 | director |
| | 2020-09-02 | director |
| | 2023-06-15 | director |
| | 2023-06-22 | director |
Charles M Baum Latest Holdings Summary
Charles M Baum currently owns a total of 2 stocks. Among these stocks, Charles M Baum owns 168,777 shares of Mirati Therapeutics Inc (MRTX) as of January 4, 2023, with a value of $10 Million and a weighting of 96.22%. Charles M Baum also owns 10,000 shares of Array BioPharma Inc (ARRY) as of February 9, 2018, with a value of $389,500 and a weighting of 3.78%.
Latest Holdings of Charles M Baum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MRTX | Mirati Therapeutics Inc | 2023-01-04 | 168,777 | 58.70 | 9,907,210 |
| ARRY | Array BioPharma Inc | 2018-02-09 | 10,000 | 38.95 | 389,500 |
Holding Weightings of Charles M Baum
Charles M Baum Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles M Baum has made a total of 11 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Mirati Therapeutics Inc is the sale of 3,648 shares on January 4, 2023, which brought Charles M Baum around $169,997.
According to the SEC Form 4 filings, Charles M Baum has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the sale of 50,000 shares on February 9, 2018, which brought Charles M Baum around $845,000.
Insider Trading History of Charles M Baum
- 1
Charles M Baum Trading Performance
GuruFocus tracks the stock performance after each of Charles M Baum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles M Baum is 6.98%. GuruFocus also compares Charles M Baum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles M Baum within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles M Baum's insider trading performs compared to the benchmark.
Performance of Charles M Baum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -16.04 | | | | | |
| Relative Return to S&P 500(%) | -19.26 | | | | | |
Charles M Baum Ownership Network
Charles M Baum Owned Company Details
What does BCTG Acquisition Corp do?
Who are the key executives at BCTG Acquisition Corp?
Charles M Baum is the director of BCTG Acquisition Corp. Other key executives at BCTG Acquisition Corp include 10 percent owner Bctg Holdings, Llc , director & Chief Executive Officer Aaron I. Davis , and director & President Christopher Fuglesang .
BCTG Acquisition Corp (BCTG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BCTG Acquisition Corp (BCTG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BCTG Acquisition Corp (BCTG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BCTG Acquisition Corp (BCTG)'s detailed insider trading history can be found in Insider Trading Tracker table.
BCTG Acquisition Corp Insider Transactions
Charles M Baum Mailing Address
Above is the net worth, insider trading, and ownership report for Charles M Baum. You might contact Charles M Baum via mailing address: C/o Mirati Therapeutics Inc., 9393 Towne Centre Drive, Ste 200, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
